Skip to content. | Skip to navigation

National Cancer Institute U.S. National Institutes of Health www.cancer.gov

Navigation

Personal tools

You are here: Home / Collaborative Groups / Breast and Gynecologic Cancers Research Group / The Risk of Ovarian Malignancy Algorithm (ROMA) algorithm was approved by the FDA in 2011

The Risk of Ovarian Malignancy Algorithm (ROMA) algorithm was approved by the FDA in 2011

Click here to view more information about ROMA in the biomarker database.

Announcement 10/27/2016

Thank you to everyone who contributed to the successful and productive EDRN Orientation Meeting in October. The next EDRN Steering Committee Meeting will take place in March 6-9, 2017 in Tempe, AZ. More information about this meeting will be available soon.

Announcement